华瑞股份 reported revenue of ¥0.42B for the period ended 2026-06-30, +7.9% year on year. Net income was ¥0.01B, a 2.1% net margin on a 17.1% gross margin. The largest revenue line is 与换向器有关的主营收入 at 72% of the total. Free cash flow for the period was ¥0.06B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.42B | +7.9% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | +91.6% |
| Gross margin | 17.1% | Net margin 2.1% |
| Revenue Q/Q | +19.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 与换向器有关的主营收入 | ¥0.30B | 72.0% |
| 其他主营业务 | ¥0.12B | 27.6% |
| 与铜排、铜片有关的主营收入 | ¥0.00B | 0.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.35B | 82.9% |
| R&D | ¥0.02B | 4.1% |
| SG&A | ¥0.02B | 5.8% |
| Tax & other | ¥0.00B | 0.5% |
| Item | Amount |
|---|---|
| Total assets | ¥0.96B |
| Total liabilities | ¥0.43B |
| Shareholders' equity | ¥0.53B |
| Equity / assets | 55.5% |
| Operating cash flow | ¥0.06B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.06B |
| Cash conversion (OCF / net income) | 965% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华测导航 ・ 新劲刚 ・ 久吾高科 ・ 光莆股份 ・ 开立医疗 ・ 彩讯股份 ・ 中达安 ・ 同和药业 ・ 扬帆新材 ・ 广和通 ・ 凯普生物 ・ 德艺文创
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies